


A symposium to honour Sir Ian Wilmut FRS and to mark the opening of the new Scottish Centre for Regenerative Medicine Building.
Speakers include
Registration
Register for this event via the University of Edinburgh's e-pay system.
28 February 2012 - early registration discount ends
17 May 2012 - last booking date
Costs
Lead sponsors
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com
Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition with innovative life science products and applications. For more information please visit: www.lifetechnologies.com
Additional support from
| Attachment | Size |
|---|---|
| Symposium Driving Stem Cell Research Towards Therapy | 390.17 KB |